Earnings Labs
Vanda Pharmaceuticals Inc. logo

Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ·Healthcare·Biotechnology

$6.86

+1.03%

Mkt Cap $407.25M

Analyst Ratings

Buy

5

Hold

1

Sell

0

Price Target (5 analysts)

$14.17

Range $7.50$24.00

Implied Upside

+106.6%

Consensus $14.17 vs current $6.86